Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lixisenatide versus sulfonylurea added to basal insulin in adults with type 2 diabetes fasting during Ramadan
MOH_2017-03-08_000183Phase 4Completed
- Sponsor
- Sanofi
- Start
- Oct 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of lixisenatide in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Sanofi. Started Oct 2016; status: completed.
02
Drugs
lixisenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on MOH_2017-03-08_000183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2017-03-08_000183.